This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 Aug;21(4):357-9.

doi: 10.1097/00004714-200108000-00001.

Drug interactions with grapefruit juice: an update

D J Greenblatt, K C Patki, L L von Moltke, R I Shader

PMID: 11476118
DOI: 10.1097/00004714-200108000-00001

Review

Drug interactions with grapefruit juice: an update

D J Greenblatt et al. J Clin Psychopharmacol. 2001 Aug.

. 2001 Aug;21(4):357-9.

doi: 10.1097/00004714-200108000-00001.

Authors

D J Greenblatt, K C Patki, L L von Moltke, R I Shader

PMID: 11476118
DOI: 10.1097/00004714-200108000-00001

No abstract available

PubMed Disclaimer

Similar articles

Amlodipine and grapefruit juice.
Josefsson M, Ahlner J. Josefsson M, et al. Br J Clin Pharmacol. 2002 Apr;53(4):405; author reply 406. doi: 10.1046/j.1365-2125.2002.01572_3.x. Br J Clin Pharmacol. 2002. PMID: 11966676 Free PMC article. No abstract available.
[Grapefruit juice and drugs: a hazardous combination?].
Lohezic-Le Devehat F, Marigny K, Doucet M, Javaudin L. Lohezic-Le Devehat F, et al. Therapie. 2002 Sep-Oct;57(5):432-45. Therapie. 2002. PMID: 12611197 Review. French.
Risk of torsades de pointes with non-cardiac drugs. Grapefruit juice is source of potentially life threatening adverse drug reactions.
Marinucci P. Marinucci P. BMJ. 2001 Jan 6;322(7277):47. BMJ. 2001. PMID: 11141164 No abstract available.
Potentially serious drug interactions with grapefruit juice.
Gunston GD, Mehta U. Gunston GD, et al. S Afr Med J. 2000 Jan;90(1):41. S Afr Med J. 2000. PMID: 10721388 No abstract available.
Drug interactions with herbal products and grapefruit juice: a conference report.
Huang SM, Hall SD, Watkins P, Love LA, Serabjit-Singh C, Betz JM, Hoffman FA, Honig P, Coates PM, Bull J, Chen ST, Kearns GL, Murray MD; Center for Drug Evaluation and Research and Office of Regulatory Affairs, Food and Drug Administration, Rockville, MD, USA. Huang SM, et al. Clin Pharmacol Ther. 2004 Jan;75(1):1-12. doi: 10.1016/j.clpt.2003.07.002. Clin Pharmacol Ther. 2004. PMID: 14749688 Review. No abstract available.

See all similar articles

Cited by

Fruit juice inhibition of uptake transport: a new type of food-drug interaction.
Bailey DG. Bailey DG. Br J Clin Pharmacol. 2010 Nov;70(5):645-55. doi: 10.1111/j.1365-2125.2010.03722.x. Br J Clin Pharmacol. 2010. PMID: 21039758 Free PMC article. Review.
Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs.
Beck TC, Beck KR, Morningstar J, Benjamin MM, Norris RA. Beck TC, et al. Pharmaceuticals (Basel). 2021 May 17;14(5):472. doi: 10.3390/ph14050472. Pharmaceuticals (Basel). 2021. PMID: 34067565 Free PMC article. Review.
The influence of age and sex on the clearance of cytochrome P450 3A substrates.
Cotreau MM, von Moltke LL, Greenblatt DJ. Cotreau MM, et al. Clin Pharmacokinet. 2005;44(1):33-60. doi: 10.2165/00003088-200544010-00002. Clin Pharmacokinet. 2005. PMID: 15634031 Review.
Second-generation antihistamines: actions and efficacy in the management of allergic disorders.
Golightly LK, Greos LS. Golightly LK, et al. Drugs. 2005;65(3):341-84. doi: 10.2165/00003495-200565030-00004. Drugs. 2005. PMID: 15669879 Review.
The grapefruit: an old wine in a new glass? Metabolic and cardiovascular perspectives.
Owira PM, Ojewole JA. Owira PM, et al. Cardiovasc J Afr. 2010 Sep-Oct;21(5):280-5. doi: 10.5830/cvja-2010-012. Cardiovasc J Afr. 2010. PMID: 20972517 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Grants and funding

RR-00054/RR/NCRR NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer